Health X Platform
Healthcare Services
Sastasundar Ventures Ltd
HEALTHX NSE
₹270.80 No trade today
- P/E
- 33.06
Close 4 Nov 2026 ₹270.80 −19.05 −6.57% 1Y
Start ₹289.85
Key Fundamentals
MicrocapHealthcare ServicesHealthcarePrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- −1.33%
- Debt to Equity
- 0.01
- EPS (TTM)
- ₹8.19
- Book Value
- ₹201.47
- Market Cap
- —
- P/E (TTM)
- 33.06
- P/B
- 1.34
- ROE
- 4.63%
- Dividend Yield
- 0.00%
- EBITDA
- ₹6.20 Cr
- 52W High
- ₹363.00
- 52W Low
- ₹252.50
- Volume
- 0
Peer Comparison
Healthcare › Healthcare Services › Healthcare Service Provider
| ₹2,029.40 | 62.75 | ₹32,036 Cr | 13.58 | 0.26% | 22.30% | 28.00% | ₹2,891 Cr | ₹545 Cr | |
| ₹1,424.60 | 78.15 | ₹14,588 Cr | 15.33 | 0.14% | 18.30% | 20.50% | ₹857 Cr | ₹187 Cr | |
| ₹581.25 | 59.74 | ₹11,437 Cr | 8.03 | 0.88% | 13.60% | 17.80% | ₹1,710 Cr | ₹203 Cr | |
| ₹495.50 | 44.72 | ₹7,723 Cr | 14.25 | 2.90% | 28.40% | 35.40% | ₹876 Cr | ₹176 Cr | |
| ₹622.35 | 148.53 | ₹5,903 Cr | 5.61 | 0.00% | 8.83% | 15.30% | ₹1,053 Cr | ₹85 Cr | |
| ₹333.05 | 48.41 | ₹1,717 Cr | 7.08 | 0.15% | 14.20% | 17.30% | ₹325 Cr | ₹35 Cr | |
| ₹483.05 | 15.84 | ₹1,571 Cr | 1.51 | 0.41% | 10.90% | 12.70% | ₹726 Cr | ₹98 Cr | |
| Health X Platform (this company) | ₹270.80 | 33.06 | ₹903 Cr | 1.34 | 0.00% | 4.63% | −1.33% | ₹1,231 Cr | ₹29 Cr |
| Median 8 companies | ₹538.38 | 54.08 | ₹6,813 Cr | 7.56 | 0.21% | 13.90% | 17.55% | ₹965 Cr | ₹137 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
36 Poor
Data confidence 98/100
Category scores
- Quality
- 16
- Poor
- Returns, margins, earnings quality 22% weight
- Valuation
- 48
- Average
- Cheap vs sector & own history 24% weight
- Growth
- 33
- Poor
- Sales & profit trajectory 9% weight
- Financial Health
- 35
- Poor
- Solvency, leverage, coverage 9% weight
- Momentum
- 26
- Poor
- Trend strength, vol-adjusted 12% weight
- Ownership
- 51
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
4- Company is almost debt free.
- Company has delivered good profit growth of 23.3% CAGR over last 5 years
- Company's median sales growth is 39.5% of last 10 years
- Company's working capital requirements have reduced from 66.1 days to 47.0 days
Weaknesses
2- Company has a low return on equity of -1.12% over last 3 years.
- Earnings include an other income of Rs.66.2 Cr.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 11 | 7 | 1 |
| Oscillators | Neutral | 1 | 7 | 1 |
| Moving Averages | Strong Bearish | 10 | 0 | 0 |
Oscillators
Neutral
Bearish
1
Neutral
7
Bullish
1
Overall
Strong Bearish
Bearish
11
Neutral
7
Bullish
1
Moving Averages
Strong Bearish
Bearish
10
Neutral
0
Bullish
0
Key readings
- RSI (14)
- 40.32
- Neutral
- MACD (12,26,9)
- −2.92
- Bullish
- SMA (50)
- 288.89
- Bearish
- SMA (200)
- 293.72
- Bearish
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2025; 1Y: fiscal year to Mar 2025 against Mar 2024; TTM: four quarters to Dec 2025 against Dec 2024.
Revenue
| 10Y | +36.40% |
|---|---|
| 5Y | +24.47% |
| 3Y | −13.62% |
| 1Y | −19.06% |
| TTM | +8.80% |
Net profit
| 10Y | Loss widened by ₹119 Cr |
|---|---|
| 5Y | Loss widened by ₹82 Cr |
| 3Y | Turned to loss |
| 1Y | Turned to loss |
| TTM | Turned to profit |
Operating cash flow
| 10Y | Outflow widened by ₹5 Cr |
|---|---|
| 5Y | Outflow narrowed by ₹52 Cr |
| 3Y | Outflow narrowed by ₹190 Cr |
| 1Y | Turned negative |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | +17.59 pp |
|---|---|
| 5Y | +11.76 pp |
| 3Y | −63.60 pp |
| 1Y | +0.04 pp |
| TTM | −0.57 pp |
Revenue by year
| Mar 2016 | ₹89.00 Cr |
|---|---|
| Mar 2017 | ₹135 Cr |
| Mar 2018 | ₹162 Cr |
| Mar 2019 | ₹222 Cr |
| Mar 2020 | ₹388 Cr |
| Mar 2021 | ₹551 Cr |
| Mar 2022 | ₹1,798 Cr |
| Mar 2023 | ₹1,060 Cr |
| Mar 2024 | ₹1,432 Cr |
| Mar 2025 | ₹1,159 Cr |
Net profit by year
| Mar 2016 | −₹37.00 Cr |
|---|---|
| Mar 2017 | −₹29.00 Cr |
| Mar 2018 | −₹15.00 Cr |
| Mar 2019 | −₹43.00 Cr |
| Mar 2020 | −₹52.00 Cr |
| Mar 2021 | −₹17.00 Cr |
| Mar 2022 | ₹865 Cr |
| Mar 2023 | −₹99.00 Cr |
| Mar 2024 | ₹6.00 Cr |
| Mar 2025 | −₹134 Cr |
Analyst Forecasts
Forecast For
FY27 consensus · ROE
−13.0% −12.8 pp vs FY26
Reported High Mean Low
Quarterly Results
₹ CrResults for the period ended Mar 2026 were due by 30 May 2026 and are not in this table yet.
| Particulars | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 281 | 313 | 336 | 358 | 375 | 307 | 270 | 274 | 281 | 286 | 298 | 301 | 346 |
| Expenses | 291 | 324 | 327 | 355 | 371 | 317 | 273 | 278 | 305 | 311 | 292 | 324 | 356 |
| Operating Profit | −10.08 | −11.17 | 9.26 | 3.37 | 3.43 | −10.65 | −2.4 | −4.72 | −23.7 | −25.2 | 6.06 | −22.61 | −10.36 |
| OPM % | −3.59% | −3.57% | 2.76% | 0.94% | 0.92% | −3.47% | −0.89% | −1.73% | −8.43% | −8.82% | 2.03% | −7.5% | −3% |
| Other Income | 4.01 | 8.63 | 12.11 | 9.71 | 20.13 | 18.46 | 28.75 | −167 | −14.06 | 21.91 | 25.38 | 5.34 | 13.62 |
| Interest | 0.27 | 0.26 | 0.25 | 0.24 | 0.24 | 0.27 | 0.1 | 0.06 | 0.05 | 0.01 | 0.09 | 0.04 | 0.17 |
| Depreciation | 2.4 | 2.8 | 2.09 | 2.2 | 2.31 | 2.53 | 1.61 | 1.45 | 1.43 | 1.34 | 1.17 | 1.33 | 2.17 |
| PBT | −8.74 | −5.6 | 19.03 | 10.64 | 21 | 5.01 | 24.64 | −174 | −39.24 | −4.64 | 30.18 | −18.64 | 0.92 |
| Tax % | −70.48% | 287.5% | −28.85% | −23.03% | 3.86% | −583.03% | −102.8% | −13.17% | 1.99% | −478.45% | 11.9% | −17.17% | 59.78% |
| Net Profit | −26.37 | −48 | −0.28 | −12.2 | −3.23 | 21.58 | 40.96 | −155 | −37.8 | 17.57 | 26.59 | −15.44 | 0.37 |
| EPS (₹) | −6 | −10.75 | 0.41 | −2.55 | −0.24 | 5.17 | 9.79 | −34.39 | −8.47 | 4.3 | 7.52 | −3.99 | 0.36 |
Profit & Loss
₹ Cr| Particulars | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 30 | 52 | 89 | 135 | 162 | 222 | 388 | 551 | 1,798 | 1,060 | 1,432 | 1,159 | 1,231 |
| Expenses | 35 | 62 | 116 | 155 | 175 | 255 | 440 | 561 | 684 | 1,168 | 1,456 | 1,177 | 1,283 |
| Operating Profit | −4 | −10 | −28 | −20 | −13 | −33 | −52 | −10 | 1,114 | −107 | −24 | −19 | −52 |
| OPM % | −15% | −19% | −31% | −15% | −8% | −15% | −13% | −2% | 62% | −10% | −2% | −2% | −4% |
| Other Income | 0 | 2 | 0 | 2 | 7 | 0 | 1 | 1 | 3 | −5 | 4 | −179 | 66 |
| Interest | 1 | 1 | 2 | 3 | 1 | 3 | 1 | 3 | 3 | 2 | 1 | 0 | 0 |
| Depreciation | 2 | 6 | 7 | 7 | 6 | 6 | 5 | 4 | 4 | 8 | 9 | 6 | 6 |
| PBT | −7 | −15 | −37 | −28 | −12 | −42 | −58 | −16 | 1,109 | −122 | −30 | −204 | 8 |
| Tax % | −5% | 0% | −1% | 2% | 19% | 3% | −9% | 4% | 22% | −19% | −119% | −34% | — |
| Net Profit | −6 | −15 | −37 | −29 | −15 | −43 | −52 | −17 | 865 | −99 | 6 | −134 | 29 |
| EPS (₹) | −2.03 | −4.68 | −11.51 | −9 | −3.73 | −11.81 | −12.19 | −3.27 | 197 | −22.7 | 2.79 | −28.66 | 8.19 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 |
| Reserves | 238 | 223 | 186 | 163 | 144 | 111 | 178 | 168 | 795 | 722 | 731 | 638 | 650 |
| Borrowings | 0 | 5 | 19 | 21 | 12 | 2 | 8 | 12 | 2 | 9 | 4 | 1 | 5 |
| Other Liabilities | 39 | 22 | 20 | 35 | 48 | 86 | 98 | 80 | 449 | 441 | 383 | 300 | 321 |
| Total Liabilities | 309 | 281 | 256 | 251 | 235 | 230 | 316 | 293 | 1,278 | 1,204 | 1,149 | 970 | 1,008 |
| Fixed Assets | 117 | 137 | 126 | 125 | 117 | 116 | 114 | 110 | 93 | 107 | 110 | 102 | 117 |
| CWIP | 0 | 3 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 10 | 1 |
| Investments | 41 | 22 | 10 | 17 | 46 | 36 | 56 | 43 | 666 | 513 | 676 | 575 | 633 |
| Other Assets | 151 | 119 | 120 | 110 | 71 | 77 | 146 | 139 | 518 | 583 | 363 | 283 | 257 |
| Total Assets | 309 | 281 | 256 | 251 | 235 | 230 | 316 | 293 | 1,278 | 1,204 | 1,149 | 970 | 1,008 |
Cash Flow
₹ Cr| Particulars | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 36 | −12 | −12 | −2 | −49 | −30 | −69 | −31 | −207 | −112 | 36 | −17 |
| Investing | −42 | 7 | −1 | 4 | 15 | −2 | −22 | 21 | 220 | 133 | −34 | −1 |
| Financing | −3 | 4 | 13 | 5 | 33 | 26 | 103 | 4 | −11 | −2 | −2 | 0 |
| Net Cash Flow | −10 | −1 | 0 | 7 | −2 | −6 | 11 | −5 | 1 | 19 | 0 | −19 |
| Free Cash Flow | 15 | −28 | −18 | 0 | −55 | −33 | −71 | −31 | −212 | −128 | 22 | −27 |
| CFO/OP | −845 | 106 | 43 | 17 | 377 | 89 | 133 | 288 | −8 | 104 | −172 | 68 |
Ratios
| Particulars | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 169 | 87 | 34 | 52 | 9 | 13 | 14 | 9 | 4 | 12 | 9 | 3 |
| Inventory Days | — | 337 | 91 | 80 | 73 | 59 | 77 | 57 | 71 | 69 | 34 | 40 |
| Days Payable | — | 165 | 38 | 69 | 24 | 26 | 50 | 29 | 21 | 22 | 13 | 21 |
| Cash Conversion Cycle | 169 | 259 | 87 | 62 | 58 | 46 | 41 | 38 | 55 | 59 | 31 | 22 |
| Working Capital Days | 441 | 344 | 182 | 49 | 61 | 61 | 54 | 44 | 46 | 93 | 58 | 47 |
| ROCE % | −2% | −6% | −14% | −12% | −8% | −19% | −25% | −6% | −7% | −11% | −3% | −1% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Health X Platform insights
64 extracted metrics across FY12–FY27.
Documents
- Q1 FY27 concall · Aug 2026PPT
- Concall · Jun 2026Transcript PPT Recording
- Q4 FY26 concall · Jun 2026PPT
- Concall · Feb 2026PPT
- Q3 FY26 concall · Feb 2026Transcript PPT
- General announcements 9 Oct 2026
Frequently Asked Questions about Health X Platform
What does Sastasundar Ventures Ltd do?
Incorporated in 1989, Sastasundar Ventures Ltd is in the business of digital network of healthcare and portfolio management services
Where is Sastasundar Ventures Ltd (HEALTHX) listed?
Sastasundar Ventures Ltd trades as HEALTHX on the NSE and under code 533259 on the BSE.
Which sector does Sastasundar Ventures Ltd belong to?
Sastasundar Ventures Ltd is classified under the Healthcare Services sector, in the Healthcare Service Provider industry.
What is the PE ratio of Sastasundar Ventures Ltd?
Sastasundar Ventures Ltd trades at a PE ratio of 33.06 as of 4 Nov 2026, on earnings per share of ₹8.19, against a book value of ₹201.47 per share.
What is the 52-week high and low of Sastasundar Ventures Ltd?
Over the last 52 weeks Sastasundar Ventures Ltd has traded between ₹252.5 and ₹363 as of 4 Nov 2026.
What is the Return on Equity (ROE) of Sastasundar Ventures Ltd?
Sastasundar Ventures Ltd reported a return on equity of 4.63%. Its debt-to-equity ratio is 0.01.
Company Information
Incorporated in 1989, Sastasundar Ventures Ltd is in the business of digital network of healthcare and portfolio management services
Website sastasundarventures.com
CEO Mr. Banwari Lal Mittal
Employees 1,657
Listed 5 Oct 2010
Face Value ₹10
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/HEALTHX.md for Sastasundar Ventures Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.